![Thomas Fuchs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 97 192 $ in data 31/08/2026
Thomas Fuchs is currently an Independent Director at GeneDx Holdings Corp.
since 2025.
Dr. Fuchs is also the Chief Artificial Intelligence Officer & Senior VP at Eli Lilly & Co. since 2024.
Dr. Fuchs holds a doctorate from the Swiss Federal Institute of Technology and a graduate degree from Graz University of Technology.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/09/2026 | 1.146 ( 0% ) | 97 192 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ELI LILLY AND COMPANY | Direttore Tecnico/Scientifico/R&S | 21/10/2024 |
| GENEDX HOLDINGS CORP. | Direttore/Membro del Consiglio | 17/09/2025 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graz University of Technology
 Graz University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeneDx Holdings Corp.
 GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services | Health Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
